🔥Very Popular

Semaglutide

Also known as: Ozempic, Wegovy, Rybelsus

Weight LossHealthPerformance
FDA Approved

Primary recreational use: Weight loss and appetite suppression

What is Semaglutide?

Semaglutide is a synthetic GLP-1 receptor agonist developed by Novo Nordisk, primarily used for type 2 diabetes management and chronic weight management. It offers significant weight loss potential, with average reductions of 15-20% in body weight. The peptide is FDA-approved for both diabetes and weight management, making it a leading pharmaceutical intervention in these areas. Key concerns include gastrointestinal side effects and a boxed warning about thyroid tumors.

Primary Benefits

Significant weight loss. Improved glycemic control. Reduced cardiovascular risk.

How It Works

Semaglutide acts as a GLP-1 receptor agonist, slowing gastric emptying and enhancing insulin secretion while reducing glucagon release. By activating GLP-1 receptors, it influences brain centers to decrease hunger and increase feelings of fullness, contributing to weight loss and improved glucose control.

Safety Tips

Precautions reported in community discussions and literature. This is not a complete list.

  • 1.DON'T use if you have a history of medullary thyroid carcinoma or MEN 2.
  • 2.DON'T share needles or injection supplies.
  • 3.DON'T use compounded or counterfeit versions; use only FDA-approved products.
  • 4.DON'T inject in the same site repeatedly – rotate injection sites.
  • 5.DON'T exceed the prescribed dose; follow titration schedules to minimize side effects.

Who Should NOT Use

  • Medullary thyroid carcinoma
  • Multiple endocrine neoplasia syndrome type 2
  • Pregnancy

Use Contexts

Different purposes have different protocols, dosing, and considerations

✓Approved Medical

Type 2 diabetes management

strong evidence

Semaglutide is used to improve glycemic control in adults with type 2 diabetes, helping reduce blood sugar levels and cardiovascular risks.

Evidence: Approved for type 2 diabetes, supported by multiple SUSTAIN trials showing significant HbA1c reduction compared to other treatments.

The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.

Reported Range
0.5-1 mg
Reported Frequency
once weekly
Reported Cycle
0-0 weeks
Reported Route
Subcutaneous

Timing: Morning, same day each week

Notes: Consistent timing helps monitor side effects effectively.

Pharmacokinetics

Half-Life
7 days
Time to Peak
1-3 days
Clearance
0.05 L/h

Reported Side Effects

This is not a complete list. Other side effects may occur.

Common
Nauseacommon (1-10%)
Diarrheacommon (1-10%)
Serious / Rare
  • Pancreatitis
  • Acute kidney injury
Injection-Specific Warnings
  • Rotate injection sites to prevent irritation.

Storage

Temperature
Refrigerated (2-8°C)
Reconstituted
Room temperature up to 28 days
Shelf Life
28 days
Light Sensitive
No
✓Approved Medical

Chronic weight management

strong evidence

For chronic weight management, Semaglutide is used as an adjunct to diet and exercise to help lose weight and prevent major cardiovascular events in adults with obesity or overweight and additional risk factors.

Evidence: Validated by STEP trials showing significant weight loss sustained over 2+ years.

The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.

Reported Range
1-2.4 mg
Reported Frequency
once weekly
Reported Cycle
0-0 weeks
Reported Route
Subcutaneous

Timing: Morning, same day each week

Notes: Week-to-week consistency in timing is recommended.

Pharmacokinetics

Half-Life
7 days
Time to Peak
1-3 days
Clearance
0.05 L/h

Reported Side Effects

This is not a complete list. Other side effects may occur.

Common
Nauseacommon (1-10%)
Vomitingcommon (1-10%)
Serious / Rare
  • Thyroid C-cell tumors in rodents
Injection-Specific Warnings
  • Avoid repeated use of the same injection site.

Storage

Temperature
Refrigerated (2-8°C)
Reconstituted
Room temperature up to 28 days
Shelf Life
28 days
Light Sensitive
No

Harm Reduction Information

Quality Concerns

  • Counterfeit products are common online.
  • Compounded formulations lack regulatory assurance.

Safety Tips

  • Always use sterile injection techniques.
  • Rotate injection sites regularly.
  • Start with a lower dose to assess tolerance.

Warning Signs to Stop

  • Severe abdominal pain (pancreatitis).
  • Symptoms of thyroid tumors.

Seek Medical Help Immediately If

  • Signs of severe abdominal pain or pancreatitis.
  • Allergic reactions or breathing difficulties.

Frequently Asked Questions

Common questions about Semaglutide

How long until I see effects?

With Semaglutide, appetite reduction may begin within 1-2 weeks and significant weight loss can be observed within 4-8 weeks.

What time of day should I take it?

Semaglutide should be taken once weekly on the same day each week, ideally in the morning to monitor side effects.

How can I minimize side effects?

Starting with the lowest dose and titrating slowly can help minimize gastrointestinal side effects when using Semaglutide.

Does tolerance develop?

Semaglutide does not typically lead to tolerance development as long as dosing guidelines are followed.

How should I store it?

Store Semaglutide refrigerated at 2-8°C before use. After first use, it can be kept at room temperature for up to 28 days.

Do I need to cycle it?

No cycling is required for Semaglutide; it is intended for ongoing treatment as prescribed.

Can I combine it with other peptides?

Semaglutide is compatible with certain other peptides like BPC-157 but consult a healthcare provider before combining.

What happens if I miss a dose?

If you miss a dose of Semaglutide and it's within 5 days, take it as soon as remembered; otherwise, skip it and maintain your schedule.

Reported Combinations

Compounds reported to be used alongside Semaglutide in community discussions

off label-medical

BPC-157

Enhanced healing properties when combined.

off label-medical

Tirzepatide

Additive effects on weight loss.

off label-medical

Cagrilintide

Synergistic effect on appetite suppression.

Reported Interactions

Interactions reported in literature and community discussions.

Insulinmajor

Increased risk of hypoglycemia.

Sulfonylureasmajor

May enhance hypoglycemia risk.

Metforminmoderate

Compatible but monitor for hypoglycemic events.

Growth hormone peptidesminor

Compatible. No direct interaction.

Multivitaminsminor

Generally safe with concurrent use.

Reconstitution Calculator

mL
U100 insulin syringe01020304050607080901001mL

100 units = 1 mL

Safety Tips

  • Always consult a licensed medical professional for dosing and reconstitution instructions.
  • Always double check your units. Mixing up mg and mcg can be very dangerous.
  • Make sure to select your syringe type. U-100 and U-50 syringes have different units.
  • Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.

This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.

Explore More Research

Browse our database of peptide research information compiled from published literature and community sources.

Browse All PeptidesAbout Pepbase App

Citations

Last updated: October 3, 2023

Important Disclaimer

AI-Generated Content Notice

The information on this page has been compiled using artificial intelligence (AI) and large language model (LLM) technology from multiple sources including published literature, online communities, and public databases. This content may contain errors, inaccuracies, outdated information, or omissions. We make no guarantees regarding the accuracy, completeness, or reliability of any information presented. You are solely responsible for independently verifying any information before relying on it.

Not Medical Advice

Nothing on this website constitutes medical advice, diagnosis, or treatment recommendations. The information provided is for educational and harm-reduction purposes only. We do not provide individualized dosing guidance or treatment recommendations. Protocols and dosing information shown represent reports from community discussions and published literature—they are not endorsements or recommendations. Always consult with a licensed healthcare professional before making any health-related decisions.

No Endorsement of Use

Pepbase does not endorse, encourage, or recommend the use of any peptide or substance discussed on this website. Many compounds discussed are not approved for human use by the FDA or other regulatory agencies. Some substances may be illegal to possess, sell, or use in your jurisdiction. We do not facilitate or encourage the procurement, distribution, or use of controlled or prescription-only substances. Users are solely responsible for understanding and complying with all applicable laws in their jurisdiction.

Calculators and Tools

Any calculators, estimators, or tools provided on this website are for informational purposes only and produce estimates that may be inaccurate. Errors in calculations can result in serious harm. You are solely responsible for verifying all calculations independently. These tools do not account for individual factors that may affect dosing and should never be relied upon as a substitute for professional medical guidance.

Assumption of Risk

By using this website, you acknowledge that you understand the risks associated with using unregulated substances and that you assume full responsibility for your own health decisions. Pepbase, its creators, contributors, and affiliates disclaim all liability for any harm, injury, or damages arising from the use or misuse of information on this website. Use of any information on this site is entirely at your own risk.

If you are experiencing a medical emergency, call emergency services immediately. If you have questions about medications or supplements, consult a licensed pharmacist or physician.